Education
About Us
Working with TipRanks
Follow Us
Aspire Biopharma Holdings (ASBP)
NASDAQ:ASBP
RESEARCH TOOLSreports
| Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -1.34M | $ -5.29M | $ -25.48K |
| EBITDA | $ 5.80M | $ 4.32M | $ -25.48K |
| Net Income | $ 4.46M | $ 7.66M | $ -25.48K |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 0.00 | $ 497.26K | $ 0.00 |
| Total Assets | $ 19.98M | $ 300.18M | $ 293.22K |
| Total Debt | $ 12.38K | $ 0.00 | $ 238.60K |
| Net Debt | $ 12.38K | $ -497.26K | $ 238.60K |
| Total Liabilities | $ 403.33K | $ 11.12M | $ 293.70K |
| Stockholders' Equity | $ 19.58M | $ 289.07M | $ -475.00 |
| Cash Flow | |||
| Free Cash Flow | $ -653.11K | $ -1.41M | - |
| Operating Cash Flow | $ -653.11K | $ -1.41M | - |
| Investing Cash Flow | $ 284.92M | $ -294.69M | $ 0.00 |
| Financing Cash Flow | $ -284.76M | $ 296.59M | - |
Aspire Biopharma Holdings Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.